Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lineage Cell Therapeutics (LCTX) Tax Rate (2019 - 2023)

Lineage Cell Therapeutics (LCTX) has 4 years of Tax Rate data on record, last reported at 29.05% in Q1 2023.

  • For Q1 2023, Tax Rate changed N/A year-over-year to 29.05%; the TTM value through Dec 2023 reached 7.74%, down 2834.0%, while the annual FY2025 figure was 7.69%, N/A changed from the prior year.
  • Tax Rate reached 29.05% in Q1 2023 per LCTX's latest filing, up from 15.93% in the prior quarter.
  • Across five years, Tax Rate topped out at 262.3% in Q4 2019 and bottomed at 15.93% in Q4 2022.
  • Average Tax Rate over 3 years is 38.49%, with a median of 3.88% recorded in 2019.